Search research articles
Contact Us
Filters
Showing results (161-170 of 198) with videos related to
Page
of 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 21, 2019
Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease
Grace Hyun J Kim, Donald P Tashkin, Pechin Lo, et al.
Arthritis Care & Research
|
March 14, 2022
Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts
Nancy Wareing, Vishnu Mohan, Rana Taherian, et al.
ACR Open Rheumatology
|
December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II
Elizabeth R Volkmann, Virginia Steen, Ning Li, et al.
The Journal of Rheumatology
|
February 17, 2019
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
CHEST Pulmonary
|
September 8, 2025
Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study
Angela Kaczorowski-Worthley, Dinesh Pal Mudaranthakam, Janell Reichuber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 13, 2021
Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
Masataka Kuwana, Yannick Allanore, Christopher P Denton, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.
Chest
|
December 26, 2016
Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II
Donald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, et al.
Arthritis Care & Research
|
March 2, 2010
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus
Elizabeth R Volkmann, Jennifer M Grossman, Lori J Sahakian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Masatoshi Hotta, Grace Hyun J Kim, Vilasinee Rerkpichaisuth, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 198) with videos related to
Sort By:
Page
of 20
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 21, 2019
Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease
Grace Hyun J Kim, Donald P Tashkin, Pechin Lo, et al.
Arthritis Care & Research
|
March 14, 2022
Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts
Nancy Wareing, Vishnu Mohan, Rana Taherian, et al.
ACR Open Rheumatology
|
December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II
Elizabeth R Volkmann, Virginia Steen, Ning Li, et al.
The Journal of Rheumatology
|
February 17, 2019
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
CHEST Pulmonary
|
September 8, 2025
Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study
Angela Kaczorowski-Worthley, Dinesh Pal Mudaranthakam, Janell Reichuber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 13, 2021
Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
Masataka Kuwana, Yannick Allanore, Christopher P Denton, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis
Elizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.
Chest
|
December 26, 2016
Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II
Donald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, et al.
Arthritis Care & Research
|
March 2, 2010
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus
Elizabeth R Volkmann, Jennifer M Grossman, Lori J Sahakian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Masatoshi Hotta, Grace Hyun J Kim, Vilasinee Rerkpichaisuth, et al.
Page
of 20